Downregulated expressions of p27 and ERα can enhance tamoxifen resistance by secreting miR-221/222 in exosomes for ER-positive and tamoxifen-sensitive breast cancer cells (66). The gene discussed is CDKN1B; the disease is breast carcinoma.